Pianigiani T, Paggi I, Cooper G, Staples K, McDonnell M, Bergantini L
ERJ Open Res. 2025; 11(2).
PMID: 40071269
PMC: 11895099.
DOI: 10.1183/23120541.00683-2024.
Zhou L, Han C, Zhou Y
Int J Chron Obstruct Pulmon Dis. 2025; 20:171-179.
PMID: 39867990
PMC: 11766290.
DOI: 10.2147/COPD.S489650.
Di Chiara C, Sartori G, Fantin A, Castaldo N, Crisafulli E
Medicina (Kaunas). 2025; 61(1).
PMID: 39859079
PMC: 11766895.
DOI: 10.3390/medicina61010097.
Simpson M, Kapfumvuti R, Niranjan S, Sherman M, Hassan A, Mutabi E
J Thorac Dis. 2025; 16(12):8538-8549.
PMID: 39831232
PMC: 11740058.
DOI: 10.21037/jtd-24-932.
Wu H, Zhong Y, Li Y, Zhou X, Zhao T, Wan D
Int J Chron Obstruct Pulmon Dis. 2025; 20():69-81.
PMID: 39802038
PMC: 11725259.
DOI: 10.2147/COPD.S486262.
Pain and Dyspnea During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Documentation Audit 2019-2020.
Clarke S, Williams M, Johnston K, Lee A
J Clin Med. 2025; 14(1.
PMID: 39797334
PMC: 11720982.
DOI: 10.3390/jcm14010252.
Preclinical Identification of Poorly Controlled COPD: Patients with a Single Moderate Exacerbation Matter Too.
Maya Viejo J, Navarro Ros F
J Clin Med. 2025; 14(1.
PMID: 39797105
PMC: 11721692.
DOI: 10.3390/jcm14010022.
Advances on the Role of Lung Macrophages in the Pathogenesis of Chronic Obstructive Pulmonary Disease in the Era of Single-Cell Genomics.
Li X, Zhang H, Chi X, Ruan W, Meng X, Deng J
Int J Med Sci. 2025; 22(2):298-308.
PMID: 39781522
PMC: 11704685.
DOI: 10.7150/ijms.100160.
Prognostic value of procalcitonin in acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Qiyuan P, Changyang L, Gaigai L, Ju Q, Xun Z
PLoS One. 2025; 19(12):e0312099.
PMID: 39774531
PMC: 11684632.
DOI: 10.1371/journal.pone.0312099.
Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review.
Zailani H, Satyanarayanan S, Liao W, Su K, Chang J
Curr Nutr Rep. 2025; 14(1):12.
PMID: 39760917
DOI: 10.1007/s13668-024-00599-9.
A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection.
Branche A, Ramesh M, Francis B
Infect Dis Ther. 2024; 14(Suppl 1):39-61.
PMID: 39739198
PMC: 11724830.
DOI: 10.1007/s40121-024-01081-3.
A 7-point evidence-based care discharge protocol for patients hospitalized for exacerbation of COPD: consensus strategy and expert recommendation.
Salvi S, Ghorpade D, Nair S, Pinto L, Singh A, Venugopal K
NPJ Prim Care Respir Med. 2024; 34(1):44.
PMID: 39706845
PMC: 11662074.
DOI: 10.1038/s41533-024-00378-7.
Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study).
Baydar Toprak O, Polatli M, Baha A, Kokturk N, Yapar D, Ozkan S
Medicine (Baltimore). 2024; 103(48):e40483.
PMID: 39612431
PMC: 11608697.
DOI: 10.1097/MD.0000000000040483.
Cilomilast Modulates Rhinovirus-Induced Airway Epithelial ICAM-1 Expression and IL-6, CXCL8 and CCL5 Production.
Zhu J, Edwards M, Message S, Stanciu L, Johnston S, Jeffery P
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598462
PMC: 11597196.
DOI: 10.3390/ph17111554.
Interplay between Lung Diseases and Viral Infections: A Comprehensive Review.
Suri C, Pande B, Suhasini Sahithi L, Sahu T, Verma H
Microorganisms. 2024; 12(10).
PMID: 39458339
PMC: 11510474.
DOI: 10.3390/microorganisms12102030.
Impact of exacerbation history on future risk and treatment outcomes in chronic obstructive pulmonary disease patients: A prospective cohort study based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) A and B classifications.
Lin L, Song Q, Cheng W, Li T, Zhang P, Liu C
J Glob Health. 2024; 14:04202.
PMID: 39388682
PMC: 11466499.
DOI: 10.7189/jogh.14.04202.
Effect of pneumonia on the outcomes of acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Zheng F, Wang X
BMC Pulm Med. 2024; 24(1):496.
PMID: 39385140
PMC: 11462751.
DOI: 10.1186/s12890-024-03305-1.
Air pollution and respiratory health in patients with COPD: should we focus on indoor or outdoor sources?.
Evangelopoulos D, Zhang H, Chatzidiakou L, Walton H, Katsouyanni K, Jones R
Thorax. 2024; 79(12):1116-1123.
PMID: 39375040
PMC: 11671933.
DOI: 10.1136/thorax-2024-221874.
Biofilm infections of endobronchial valves in COPD patients after endoscopic lung volume reduction: a pilot study with FISHseq.
Pappe E, Hubner R, Saccomanno J, Ebrahimi H, Witzenrath M, Wiessner A
Sci Rep. 2024; 14(1):23078.
PMID: 39366990
PMC: 11452729.
DOI: 10.1038/s41598-024-73950-3.
Clinical efficacy and safety of the self-developed Zangsiwei Qingfei Mixture combined with conventional treatment in patients with acute exacerbation of chronic obstructive pulmonary disease.
Yi Q, Li F, Lei S, Peng F, Zhang Q, Wu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(6):921-931.
PMID: 39311788
PMC: 11420969.
DOI: 10.11817/j.issn.1672-7347.2024.230546.